hat
Etid yo montre ke dòz ki ka geri nan testostewòn gen anpil ti efè negatif sou kolestewòl, men dòz yo menm ka siprize HDL kolestewòl pa otan ke 25% lè yo konbine avèk yon AI. Lè testostewòn ap administre nan yon nivo siprasyolojik, yon nivo minimòm de HDL repwesyon nòmalman espere. Lè yo menm nivo dòz la konjwen ak yon done AI montre ke yon 20% oswa pi gwo repwesyon nan kolestewòl HDL se yon posibilite anpil reyèl.
eng
Studies have shown that therapeutic doses of testosterone have very little negative effect on cholesterol but the same doses can suppress HDL cholesterol by as much as 25% when combined with an AI. When testosterone is administered at a supraphysiological level, a minimal level of HDL suppression is normally expected. When the same dosing level is conjoined with an AI data shows that a 20% or greater suppression of HDL cholesterol is a very real possibility.